 | Up a level |
Aeberhard, J; Haeberli, G; Müller, UR; Helbling, Arthur (2017). Specific Immunotherapy in Hymenoptera Venom Allergy and Concomitant Malignancy: A Retrospective Follow-up Focusing on Effectiveness and Safety. Journal of investigational allergology & clinical immunology, 27(6), pp. 370-377. Esmon Publicidad 10.18176/jiaci.0184
Jandus, P; Hausmann, O; Haeberli, G; Gentinetta, T; Mueller, U; Helbling, A (2011). Unpredicted adverse reaction to omalizumab. Journal of investigational allergology & clinical immunology, 21(7), pp. 563-6. Barcelona: Esmon Publicidad
Borer-Reinhold, M; Haeberli, G; Bitzenhofer, M; Jandus, P; Hausmann, O; Fricker, M; Helbling, A; Müller, U (2011). An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients. Clinical and experimental allergy, 41(12), pp. 1777-83. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2222.2011.03848.x
Hausmann, O; Jandus, P; Haeberli, G; Müller, UR; Helbling, A (2010). Insektengiftallergie - wichtigeste Auslöser sind Wespen- und Bienenstiche. In: Schweiz Med Forum
